参考文献
[1] Wan L, Yu W, Shen E, et al. SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer[J]. Gut, 2019, 68(1): 118-129. (IF:17.943 锐博服务:RIP-Seq 研究领域:结直肠癌 浙江大学)
了解更多详细信息请登录锐博生物官网 https://www.ribobio.com/